Development and internal validation of a diagnostic prediction model for advanced liver fibrosis based on routine laboratory indicators
Laboratory Medicine · 05.10.2026 · 57 (6)
DOI: 10.1093/labmed/lmag053 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Laboratory Medicine, online erschienen am 09.10.2026. Verfasst von Junjie Deng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Laboratory Center, Xinjiang Medical University Affiliated Traditional Chinese Medicine Hospital, Urumqi, Xinjiang, People's Republic of Chin…. Hauptthemen laut MEDLINE: Liver Cirrhosis, Diagnostic Tests, Routine. Die Arbeit nennt 35 Literaturangaben. Gefördert von: Xinjiang Strategic Talent Training Program.
Abstract (Originalsprache)
Introduction
Advanced liver fibrosis is a clinically important stage of chronic liver disease. We developed and internally validated an interpretable model based on routine laboratory tests and benchmarked it against the aspartate aminotransferase to platelet ratio index (APRI) and 4-factor fibrosis index (FIB-4).
Methods
This single-center, retrospective, diagnostic prediction study included 1853 inpatients, of whom 988 had report-defined F3 to F4 fibrosis. Primary validation used 10 repeated, stratified 7:3 outer resamples, with preprocessing, least absolute shrinkage and selection operator selection, and model refitting restricted to each development subset. Discrimination, calibration, decision curves, precision recall performance, and linear SHapley Additive exPlanations values were evaluated.
Results
The leakage-aware pipeline achieved a mean (SD) validation area under the curve of 0.800 (0.015), accuracy of 0.753, sensitivity of 0.775, and specificity of 0.729. The final logistic model included platelet count, total bile acids, C3 and C4, red blood cell count, lymphocyte count, and albumin level. In the representative test set, its area under the curve was 0.809 (95% CI, 0.772-0.845) compared with 0.815 for APRI and 0.821 for FIB-4; neither paired difference was statistically significant after Holm adjustment.
Discussion
The model showed moderate discrimination and interpretable output but was not superior to APRI or FIB-4. External validation is required before clinical implementation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Laboratory Center, Xinjiang Medical University Affiliated Traditional Chinese Medicine Hospital, Urumqi, Xinjiang, People's Republic of China.
- Clinical Laboratory Center, State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Tumor Hospital Affiliated to Xinjiang Medical University, Urumqi, Xinjiang, People's…
- Basic Medical College of Xinjiang Medical University, Urumqi, Xinjiang, China.
ORCID-Profile: Xiumin Ma
Förderung
- Xinjiang Strategic Talent Training Program
Zitieren
APA
Deng, J., Song, W., Ma, Y., Fan, B., Ma, X., & Liu, Y. (2026). Development and internal validation of a diagnostic prediction model for advanced liver fibrosis based on routine laboratory indicators. Laboratory Medicine, 57(6). https://doi.org/10.1093/labmed/lmag053
Vancouver
Deng J, Song W, Ma Y, Fan B, Ma X, Liu Y. Development and internal validation of a diagnostic prediction model for advanced liver fibrosis based on routine laboratory indicators. Laboratory Medicine. 2026;57(6). doi:10.1093/labmed/lmag053
BibTeX
@article{Deng2026,
author = {Deng, Junjie and Song, Wen and Ma, Yuyu and Fan, Bin and Ma, Xiumin and Liu, Yumei},
title = {Development and internal validation of a diagnostic prediction model for advanced liver fibrosis based on routine laboratory indicators},
journal = {Laboratory Medicine},
year = {2026},
volume = {57},
number = {6},
doi = {10.1093/labmed/lmag053}
}
EUVIMED